152 related articles for article (PubMed ID: 34877787)
1. Prognostic death factors in secondary hemophagocytic lymphohistiocytosis children with multiple organ dysfunction syndrome receiving continuous renal replacement therapy: A multicenter prospective nested case-control study.
Cui Y; Shi J; Lu G; Wang Y; Zhu X; Ren H; Zhu Y; Yan G; Wang C; Zhang Y
Ther Apher Dial; 2022 Oct; 26(5):1023-1029. PubMed ID: 34877787
[TBL] [Abstract][Full Text] [Related]
2. Analysis of risk factors for death in 59 cases of critically ill neonates receiving continuous renal replacement therapy: a two-centered retrospective study.
Xu J; Chu X; Zhang W; Sun Y; Qiu G; Cai C; Chen D
Eur J Pediatr; 2023 Jan; 182(1):353-361. PubMed ID: 36369399
[TBL] [Abstract][Full Text] [Related]
3. An unusual cause of multiple organ dysfunction syndrome in the pediatric intensive care unit: hemophagocytic lymphohistiocytosis.
Karapinar B; Yilmaz D; Balkan C; Akin M; Ay Y; Kvakli K
Pediatr Crit Care Med; 2009 May; 10(3):285-90. PubMed ID: 19433941
[TBL] [Abstract][Full Text] [Related]
4. Hemophagocytic Lymphohistiocytosis in a PICU of a Developing Economy: Clinical Profile, Intensive Care Needs, Outcome, and Predictors of Mortality.
Parajuli B; Angurana SK; Awasthi P; Nallasamy K; Baranwal A; Bansal A; Bansal D; Rawat A; Varma N; Jayashree M
Pediatr Crit Care Med; 2021 Jan; 22(1):e44-e57. PubMed ID: 33031348
[TBL] [Abstract][Full Text] [Related]
5. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
Demirkol D; Yildizdas D; Bayrakci B; Karapinar B; Kendirli T; Koroglu TF; Dursun O; Erkek N; Gedik H; Citak A; Kesici S; Karabocuoglu M; Carcillo JA;
Crit Care; 2012 Dec; 16(2):R52. PubMed ID: 22715953
[TBL] [Abstract][Full Text] [Related]
6. Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy.
Goldstein SL; Somers MJ; Baum MA; Symons JM; Brophy PD; Blowey D; Bunchman TE; Baker C; Mottes T; McAfee N; Barnett J; Morrison G; Rogers K; Fortenberry JD
Kidney Int; 2005 Feb; 67(2):653-8. PubMed ID: 15673313
[TBL] [Abstract][Full Text] [Related]
7. High-Volume Hemofiltration in Critically Ill Patients With Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome: A Prospective Study in the PICU.
Cui Y; Zhang YC; Kang YL; Ren YQ; Miao HJ; Wang F
Pediatr Crit Care Med; 2016 Oct; 17(10):e437-e443. PubMed ID: 27487914
[TBL] [Abstract][Full Text] [Related]
8. [Effect of continuous renal replacement therapy started at different time on patients with multiple organ dysfunction syndrome].
Yao LQ; Jin ZC; Ji MS; Xia CY; Yu ZX; Liu J; Hu XL; Yan J
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1663-7. PubMed ID: 21914312
[TBL] [Abstract][Full Text] [Related]
9. Etiologies and Clinical Outcomes of Patients With Secondary Hemophagocytic Lymphohistiocytosis at a Tertiary PICU.
Dao D; Xoay TD; Galeano BK; Phuc PH; Ouellette Y
Pediatr Crit Care Med; 2019 Jul; 20(7):e311-e318. PubMed ID: 31149968
[TBL] [Abstract][Full Text] [Related]
10. Secondary hemophagocytic lymphohistiocytosis and severe sepsis/ systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation.
Castillo L; Carcillo J
Pediatr Crit Care Med; 2009 May; 10(3):387-92. PubMed ID: 19325510
[TBL] [Abstract][Full Text] [Related]
11. A Report of 7-Year Experience on Pediatric Continuous Renal Replacement Therapy.
Yetimakman AF; Kesici S; Tanyildiz M; Bayrakci US; Bayrakci B
J Intensive Care Med; 2019; 34(11-12):985-989. PubMed ID: 28820041
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 1 Receptor Antagonist Anakinra, Intravenous Immunoglobulin, and Corticosteroids in the Management of Critically Ill Adult Patients With Hemophagocytic Lymphohistiocytosis.
Wohlfarth P; Agis H; Gualdoni GA; Weber J; Staudinger T; Schellongowski P; Robak O
J Intensive Care Med; 2019 Sep; 34(9):723-731. PubMed ID: 28631531
[TBL] [Abstract][Full Text] [Related]
13. Continuous renal replacement therapy in children: fluid overload does not always predict mortality.
de Galasso L; Emma F; Picca S; Di Nardo M; Rossetti E; Guzzo I
Pediatr Nephrol; 2016 Apr; 31(4):651-9. PubMed ID: 26563114
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of High-Risk Clinical Factors of Early Death in Secondary Hemophagocytic Lymphohistiocytosis].
Zhu JL; Wu F; Hu LH; Zhai ZM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1866-1871. PubMed ID: 38071074
[TBL] [Abstract][Full Text] [Related]
15. Adjustments to pharmacologic therapies for hemophagocytic lymphohistiocytosis while on extracorporeal support.
Weyand AC; Barbaro RP; Walkovich KJ; Frame DG
Pediatr Blood Cancer; 2021 Jun; 68(6):e29007. PubMed ID: 33751818
[TBL] [Abstract][Full Text] [Related]
16. Hepatobiliary Dysfunction and Disseminated Intravascular Coagulation Increase Risk of Mortality in Pediatric Hemophagocytic Lymphohistiocytosis.
Goldman J; Desai MS; McClain KL; Tcharmtchi MH; Kennedy CE; Thompson K; Lam F; Bashir DA; Chinn IK; Goldberg BR; Allen CE; Nguyen TC
Pediatr Crit Care Med; 2018 Oct; 19(10):e522-e530. PubMed ID: 30113519
[TBL] [Abstract][Full Text] [Related]
17. Fluid balance after continuous renal replacement therapy initiation and outcome in paediatric multiple organ failure.
Andersson A; Norberg Å; Broman LM; Mårtensson J; Fläring U
Acta Anaesthesiol Scand; 2019 Sep; 63(8):1028-1036. PubMed ID: 31157412
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosis.
Zhang Q; Zhu L; Zhou D; Li L; Xie W; Tan Y; Ye X
Ann Hematol; 2023 Sep; 102(9):2301-2308. PubMed ID: 37266671
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*.
Rajasekaran S; Kruse K; Kovey K; Davis AT; Hassan NE; Ndika AN; Zuiderveen S; Birmingham J
Pediatr Crit Care Med; 2014 Jun; 15(5):401-8. PubMed ID: 24583503
[TBL] [Abstract][Full Text] [Related]
20. Outcomes Analysis of Children Diagnosed With Hemophagocytic Lymphohistiocytosis in the PICU.
Gregory J; Greenberg J; Basu S
Pediatr Crit Care Med; 2019 Apr; 20(4):e185-e190. PubMed ID: 30520798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
